Tyro Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Tyro Capital Management's EWTX Position: Q3 2026 in Review
Tyro Capital Management increased its Edgewise Therapeutics (EWTX) stake by 7.9% in Q3 2026, buying an estimated $2.07M and bringing the position to 661,659 shares worth $26.9M. The position accounts for 4.76% of the portfolio, ranked #9.
Tyro Capital Management first reported a position in EWTX in Q2 2026 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Tyro Capital Management held 661,659 shares of Edgewise Therapeutics worth $26.9M as of Q3 2026.
- Tyro Capital Management bought 48,694 Edgewise Therapeutics shares in Q3 2026, an estimated $2.07M.
- Edgewise Therapeutics made up 4.76% of Tyro Capital Management's portfolio in Q3 2026, its #9 holding.
- Tyro Capital Management first reported a position in Edgewise Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 253 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Tyro Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.